[go: up one dir, main page]

SG116433A1 - S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof. - Google Patents

S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof.

Info

Publication number
SG116433A1
SG116433A1 SG200107147A SG200107147A SG116433A1 SG 116433 A1 SG116433 A1 SG 116433A1 SG 200107147 A SG200107147 A SG 200107147A SG 200107147 A SG200107147 A SG 200107147A SG 116433 A1 SG116433 A1 SG 116433A1
Authority
SG
Singapore
Prior art keywords
type
preparation
ester compounds
substituted hydroxy
residue
Prior art date
Application number
SG200107147A
Other languages
English (en)
Inventor
Kawaguchi Takayuki
Nomura Sumihiro
Tsujihara Kenji
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of SG116433A1 publication Critical patent/SG116433A1/en

Links

Classifications

    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333—Constructional arrangements; Manufacturing methods
    • G02F1/1345—Conductors connecting electrodes to cell terminals
    • G02F1/13452—Conductors connecting driver circuitry and terminals of panels
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/1303—Apparatus specially adapted to the manufacture of LCDs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Nonlinear Science (AREA)
  • Optics & Photonics (AREA)
  • Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Manufacturing & Machinery (AREA)
  • Mathematical Physics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SG200107147A 1996-10-30 1997-10-23 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof. SG116433A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28807496 1996-10-30

Publications (1)

Publication Number Publication Date
SG116433A1 true SG116433A1 (en) 2005-11-28

Family

ID=17725479

Family Applications (4)

Application Number Title Priority Date Filing Date
SG200107147A SG116433A1 (en) 1996-10-30 1997-10-23 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof.
SG9703851A SG88737A1 (en) 1996-10-30 1997-10-23 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
SG200107149A SG104284A1 (en) 1996-10-30 1997-10-23 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
SG200107148A SG103322A1 (en) 1996-10-30 1997-10-23 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof

Family Applications After (3)

Application Number Title Priority Date Filing Date
SG9703851A SG88737A1 (en) 1996-10-30 1997-10-23 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
SG200107149A SG104284A1 (en) 1996-10-30 1997-10-23 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
SG200107148A SG103322A1 (en) 1996-10-30 1997-10-23 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof

Country Status (14)

Country Link
US (7) US5932732A (fr)
EP (3) EP1236728B1 (fr)
KR (5) KR100474496B1 (fr)
CN (3) CN1077109C (fr)
AT (2) ATE247120T1 (fr)
CA (2) CA2533685C (fr)
DE (2) DE69736308T2 (fr)
DK (2) DK1236728T3 (fr)
ES (2) ES2267879T3 (fr)
HK (2) HK1050356B (fr)
ID (1) ID18747A (fr)
PT (2) PT845464E (fr)
SG (4) SG116433A1 (fr)
TW (1) TW464652B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG116433A1 (en) * 1996-10-30 2005-11-28 Tanabe Seiyaku Co S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof.
AU2002246510B2 (en) 2000-11-09 2007-09-20 Neopharm, Inc. SN-38 lipid complexes and methods of use
US20090137816A1 (en) * 2000-12-15 2009-05-28 Kurt Baum Process for the manufacture of diaminofurazan
US6350756B1 (en) 2001-01-18 2002-02-26 California Pacific Medical Center Camptothecin derivatives
AR035684A1 (es) 2001-02-21 2004-06-23 Yakult Honsha Kk Procedimiento para preparar 2'-amino-5'-hidroxipropiofenona, uso de la misma para la preparacion de analogos de camptotecina, procedimiento para prepararlos, compuestos intermediarios, procedimiento para preparar una cetona triciclica utilizada en la sintesis de analogos de camptotecina
CN101337900B (zh) * 2001-02-21 2013-12-18 株式会社雅库路特本社 喜树碱相关化合物的合成方法
US6855720B2 (en) 2001-03-01 2005-02-15 California Pacific Medical Center Nitrogen-based camptothecin derivatives
US6403604B1 (en) 2001-03-01 2002-06-11 California Pacific Medical Center Nitrogen-based camptothecin derivatives
WO2003030864A1 (fr) * 2001-05-29 2003-04-17 Neopharm, Inc. Formulation liposomale d'irinotecan
AU2003243380A1 (en) * 2002-06-03 2003-12-19 California Pacific Medical Center Nitrogen-based homo-camptothecin derivatives
US20040034050A1 (en) * 2002-06-03 2004-02-19 Yang Li-Xi Homo-camptothecin derivatives
US20060030578A1 (en) * 2002-08-20 2006-02-09 Neopharm, Inc. Pharmaceutically active lipid based formulation of irinotecan
WO2004035032A2 (fr) * 2002-08-20 2004-04-29 Neopharm, Inc. Formulation de sn-38 a base de lipides pharmaceutiquement actifs
JP4433918B2 (ja) * 2004-07-15 2010-03-17 コニカミノルタエムジー株式会社 画像形成方法
KR100651728B1 (ko) * 2004-11-10 2006-12-06 한국전자통신연구원 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
CN100390177C (zh) * 2004-11-25 2008-05-28 复旦大学 6-氰基-7-甲基-1,1-(2,2-二甲基-1,3-亚丙二氧基)-5-氧-1,2,3,5-四氢吲哚哩啶(i)的制备方法
EP1910269B1 (fr) * 2005-08-03 2013-09-18 Avra Laboratories PVT. Ltd. Procede de synthese d'intermediaires cles pour la production de derives de camptothecine
US7875602B2 (en) * 2005-10-21 2011-01-25 Sutter West Bay Hospitals Camptothecin derivatives as chemoradiosensitizing agents
CN104341429B (zh) * 2013-07-29 2016-08-10 北大方正集团有限公司 (s)-喜树碱中间体的制备方法及(s)-喜树碱的制备方法
AR114473A1 (es) * 2018-04-06 2020-09-09 Seattle Genetics Inc Conjugados péptido-camptotecina
TWI851577B (zh) 2018-06-07 2024-08-11 美商思進公司 喜樹鹼結合物
CN113041841B (zh) * 2021-03-22 2022-07-12 万华化学集团股份有限公司 一种抗污染浓水隔网的制备方法及应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0220601B1 (fr) * 1985-10-21 1991-12-11 Daiichi Seiyaku Co., Ltd. Dérivés de la pyranoindolizine et procédé de préparation

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399282A (en) * 1979-07-10 1983-08-16 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives
JPS5711607A (en) * 1980-06-25 1982-01-21 Tokyo Shibaura Electric Co Movable shelf control apparatus
JPS57116074A (en) 1981-01-09 1982-07-19 Yakult Honsha Co Ltd Novel camptothecin derivative and its preparation
US4473692A (en) * 1981-09-04 1984-09-25 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
US4981968A (en) * 1987-03-31 1991-01-01 Research Triangle Institute Synthesis of camptothecin and analogs thereof
US5053512A (en) * 1987-04-14 1991-10-01 Research Triangle Institute Total synthesis of 20(S) and 20(R)-camptothecin and compthothecin derivatives
US5244903A (en) * 1987-03-31 1993-09-14 Research Triangle Institute Camptothecin analogs as potent inhibitors of topoisomerase I
US5122606A (en) * 1987-04-14 1992-06-16 Research Triangle Institute 10,11-methylenedioxy camptothecins
US4939255A (en) * 1987-06-24 1990-07-03 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic camptothecin derivatives
US4943579A (en) 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
JPH0615547B2 (ja) * 1988-01-20 1994-03-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
JP2524803B2 (ja) * 1988-03-29 1996-08-14 株式会社ヤクルト本社 新規なカンプトテシン誘導体およびその製造法
DE69033880T2 (de) * 1989-09-15 2002-06-06 Research Triangle Institute, Research Triangle Park Verfahren zur herstellung von 10,11-Methylendioxy-20(RS)-Camptothecin und 10,11-Methylendioxy-20(S)-Camptothecin-Analog
TW201303B (fr) * 1990-07-05 1993-03-01 Hoffmann La Roche
HU213136B (en) * 1990-08-14 1997-02-28 Kyorin Seiyaku Kk Process for producing fluoroethyl camptothecin derivatives and pharmaceutical compositions containing them
JP2923692B2 (ja) * 1990-11-30 1999-07-26 第一製薬株式会社 酵素による光学分割法
JP2887524B2 (ja) * 1990-11-30 1999-04-26 第一製薬株式会社 微生物による光学分割法
JPH04210675A (ja) * 1990-12-13 1992-07-31 Otsuka Pharmaceut Co Ltd ベンゼン誘導体
DK0540099T3 (da) * 1991-10-29 1996-06-17 Glaxo Wellcome Inc Vandopløselige camptothecinderivater
CA2087898A1 (fr) * 1992-01-24 1993-07-25 Hiroshi Akimoto Composes heterocycliques condenses, leur preparation et leur utilisation
WO1993016698A1 (fr) * 1992-02-21 1993-09-02 Smithkline Beecham Corporation FURO[3',4':6,7]INDOLIZINO[1,2-b]QUINOLINONES SUBSTITUEES
JP3126798B2 (ja) * 1992-03-31 2001-01-22 第一製薬株式会社 光学活性インドリジン誘導体及びその製法
JP3126799B2 (ja) * 1992-03-31 2001-01-22 第一製薬株式会社 光学活性カンプトテシン誘導体及びその製法
JP3359955B2 (ja) * 1992-07-16 2002-12-24 第一製薬株式会社 抗腫瘍剤
IS4152A (is) * 1993-04-29 1994-10-30 Glaxo Inc. Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra
JPH07101956A (ja) * 1993-10-05 1995-04-18 Tanabe Seiyaku Co Ltd ヒドロキシカンプトテシン化合物の製法
KR960029336A (ko) * 1995-01-09 1996-08-17 김충환 캄토테신 유도체, 그의 제조 방법 및 이를 함유하는 항암제
IL117684A (en) * 1995-04-07 2002-02-10 Pharmacia & Upjohn Inc Intermediates and Process for Production of History of Kempotocin (CPT-11) and Related Compounds
US5728712A (en) * 1995-05-19 1998-03-17 Chiroscience Limited 3,4-disubstituted-phenylsulphonamides and their therapeutic use
SG50747A1 (en) * 1995-08-02 1998-07-20 Tanabe Seiyaku Co Comptothecin derivatives
DK0861236T4 (da) * 1995-11-13 2006-12-18 Sanofi Aventis Deutschland Cykliske og heterocykliske N-substituerede alphaiminohydroxam- og carboxylsyrer
WO1997019085A1 (fr) 1995-11-22 1997-05-29 Research Triangle Institute Composes de camptothecine a proprietes combinees d'inhibition de la topoisomerase i et d'alkylation de l'adn
CA2192725C (fr) * 1995-12-28 2004-04-20 Kenji Tsujihara Derives de la camptothecine
US5731316A (en) 1996-01-30 1998-03-24 The Stehlin Foundation For Cancer Research Derivatives of camptothecin and methods of treating cancer using these derivatives
SG116433A1 (en) * 1996-10-30 2005-11-28 Tanabe Seiyaku Co S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof.
DE19719817A1 (de) * 1997-05-13 1998-11-19 Hoechst Ag Substituierte 6- und 7-Aminotetrahydroisochinolincarbonsäuren

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0220601B1 (fr) * 1985-10-21 1991-12-11 Daiichi Seiyaku Co., Ltd. Dérivés de la pyranoindolizine et procédé de préparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TETRAHEDRON LETTER, VOL. 30, NO. 20, 1989, PAGES 2639-2640, STUDIES WITH CONFORMATIONALLY RESTRICTED 2-CYCLOHEXEN-1-ONE KETALS, J.ORO.CHEM., VOL.55, NO.7, PAGES 2055-2060 *

Also Published As

Publication number Publication date
MX9708343A (es) 1998-08-30
US6114529A (en) 2000-09-05
US7060832B2 (en) 2006-06-13
DE69736308T2 (de) 2007-06-14
CN1077109C (zh) 2002-01-02
KR100567957B1 (ko) 2006-04-05
DE69724081D1 (de) 2003-09-18
CA2533685A1 (fr) 1998-04-30
CN100473654C (zh) 2009-04-01
KR20060086818A (ko) 2006-08-01
KR100653592B1 (ko) 2006-12-05
HK1050356B (zh) 2007-01-19
CA2219692A1 (fr) 1998-04-30
US20030135049A1 (en) 2003-07-17
KR19980033318A (ko) 1998-07-25
CA2533685C (fr) 2009-05-26
SG88737A1 (en) 2002-05-21
KR100474496B1 (ko) 2005-09-30
EP0845464A2 (fr) 1998-06-03
CN1915995A (zh) 2007-02-21
DK1236728T3 (da) 2006-10-30
EP1236728B1 (fr) 2006-07-05
ATE332303T1 (de) 2006-07-15
EP1236728A2 (fr) 2002-09-04
EP0845464B1 (fr) 2003-08-13
US6015901A (en) 2000-01-18
TW464652B (en) 2001-11-21
ES2205134T3 (es) 2004-05-01
US6277992B1 (en) 2001-08-21
EP1236728A3 (fr) 2002-12-18
CA2219692C (fr) 2007-05-22
EP1528062A3 (fr) 2007-02-07
HK1011538A1 (en) 1999-07-16
KR100525025B1 (ko) 2005-10-31
EP1528062A2 (fr) 2005-05-04
HK1050356A1 (en) 2003-06-20
CN100528879C (zh) 2009-08-19
CN1183414A (zh) 1998-06-03
PT1236728E (pt) 2006-10-31
DE69736308D1 (de) 2006-08-17
KR100578779B1 (ko) 2006-05-12
SG103322A1 (en) 2004-04-29
ID18747A (id) 1998-05-07
SG104284A1 (en) 2004-06-21
CN1313286A (zh) 2001-09-19
ES2267879T3 (es) 2007-03-16
EP0845464A3 (fr) 1999-06-23
DK0845464T3 (da) 2003-12-01
US6716983B2 (en) 2004-04-06
US20020161231A1 (en) 2002-10-31
PT845464E (pt) 2003-12-31
US5932732A (en) 1999-08-03
ATE247120T1 (de) 2003-08-15
DE69724081T2 (de) 2004-06-09
US6388078B1 (en) 2002-05-14

Similar Documents

Publication Publication Date Title
SG103322A1 (en) S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
CY2120B1 (en) Substituted heterocyclic carboxylic acid amides their preparation and their use as medicaments
PL298988A1 (en) Novel derivatives of acetic acod, pharmaceutical preparation, method of obtaining such derivatives and method of obtaining initial compounds
PH24199A (en) Derivatives of quinoline carboxylic acid,pharmaceutical composition containing same and process of preparing same
NZ329374A (en) Tricyclic amide and urea derivatives, preparation thereof
HUT70836A (en) 1-h-indole-3-acetamide spla2 inhibitors, process for producing them and pharmaceutical compositions comprising same compounds
NZ232207A (en) Dihydrobenz(c)acridine derivatives and pharmaceutical compositions
AU4746993A (en) Azetidine compounds
EP1028118A4 (fr) Procede de production de composes de 3 cephems
AU625221B2 (en) (1,2,3,4-tetrahydro-9-acridinimino)cyclohexae carboxylic acid and related compounds, a process for their preparation and their use as medicaments
MY112574A (en) Crystals of antimicrobial compound crystals of antimicrobial compound 7-[(7-(s)-amino-5-azaspiro[2.4] 1,4-dihydroquinoline-3-carboxylic acid.
PL310621A1 (en) Method of obtaining condensed carbapeneme derivatives
EP0844247A4 (fr) Procede de production de composes 3-norcephem